Development and clinical evaluation of a rapid antibody lateral flow assay for the diagnosis of SARS-CoV-2 infection

Development and clinical evaluation of a rapid antibody lateral flow assay for the diagnosis of SARS-CoV-2 infection

Abstract Background The novel coronavirus disease 2019 (COVID-19) is an infectious disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which has quickly spread worldwide since its outbreak in December 2019. One of the primary measures for controlling the spread of SARS-Co...

Full description

Bibliographic Details
Main Authors: Kesheng Li, Chongxiang Tong, Xiaoqin Ha, Chaoning Zeng, Xia Chen, Feifei Xu, Jinhong Yang, Huifen Du, Yuxin Chen, Jing Cai, Zengwei Yang, Zhongyi Jiang, Dandan Chai, Xueliang Zhang, Xun Li, Junfeng Li, Liqiong Yao
Format: Article
Language:English
Published: BMC 2021-08-01
Series:BMC Infectious Diseases
Subjects:
Lateral flow assay
SARS-CoV-2 antibody test
SARS-CoV-2 diagnosis
Clinical application value
Online Access:https://doi.org/10.1186/s12879-021-06568-9

Internet

https://doi.org/10.1186/s12879-021-06568-9

Similar Items